Alexandria Real Estate Equities
ARE
#2390
Rank
S$10.08 B
Marketcap
S$57.88
Share price
0.85%
Change (1 day)
-18.89%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

EPS for Alexandria Real Estate Equities (ARE)

EPS in 2023 (TTM): S$1.87

According to Alexandria Real Estate Equities 's latest financial reports the company's current EPS (TTM) is S-$10.81. In 2022 the company made an earnings per share (EPS) of S$4.02 a decrease over its 2021 EPS that were of S$4.87.

EPS history for Alexandria Real Estate Equities from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S$1.87-53.52%
2022S$4.02-17.41%
2021S$4.87-35.32%
2020S$7.5289.03%
2019S$3.98-12.68%
2018S$4.56124.68%
2017S$2.03-179%
2016S-$2.57-221.95%
2015S$2.1162.38%
2014S$1.30-36.87%
2013S$2.0546.79%
2012S$1.40-36.63%
2011S$2.21-20.74%
2010S$2.79-21.66%
2009S$3.56-3.48%
2008S$3.688.3%
2007S$3.4016.23%
2006S$2.930.88%
2005S$2.90-9.27%
2004S$3.20-23.36%
2003S$4.1781.56%
2002S$2.307.19%
2001S$2.14-7.22%
2000S$2.3121.62%
1999S$1.90-8.07%
1998S$2.07-217.81%
1997S-$1.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$0.91-108.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.66-466.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$22.31-306.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S-$3.98-63.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$7.56-169.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.80-153.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$25.43-335.27%๐Ÿ‡บ๐Ÿ‡ธ USA